ArticleJAMA network open2023

Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes.

Utibe R Essien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.